SHA/603087 (SHA/603087)

Shanghai Stock Exchange: SHA/603087 · CNY

CN¥68.1

-0.25 (-0.4%)· Recorded snapshot

Market cap	40.5B
Revenue (ttm)	4.4B
Net income (ttm)	1.2B
EPS (ttm)	CN¥2.00
Shares out	595.3M
P/E (trailing)	34.0x
P/E (forward)	25.7x
Dividend	CN¥1.00 (1.47%)
Volume	7,879,590
Beta	0.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.4B
Net income (ttm): 1.2B
EPS (ttm): CN¥2.00
P/E (trailing): 34.0x
P/E (forward): 25.7x
Market cap: 40.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.7

P25 n/aP50 n/aP75 n/a

Trailing P/E34

P25 n/aP50 n/aP75 n/a

ROE10.2

P25 n/aP50 n/aP75 n/a

ROIC11

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/603087 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-28
Employees	5,309
Employees change	64
Employees growth	1.22%
Enterprise value	CNY 36.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1998
Industry	Medical Instruments & Supplies
Is primary listing	Yes
ISIN number	CNE100003ZH1
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2020-08-20
Last stock split type	Forward
Market cap	CNY 40.5B
Next earnings date	2026-10-28
Price	CNY 68.06
Price currency	CNY
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	sha/603087
Website	https://www.ganlee.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	46.51x
Average P/E ratio (5Y)	50.36x
Earnings yield	2.94%
EV/Earnings	30.85x
EV/EBIT	38.93x
EV/EBITDA	28.66x
EV/Sales	8.35x
FCF / EV yield	-1%
FCF yield	-0.9%
Forward P/E	25.68x
Graham number	30.19198
Graham upside	-55.64%
Industry forward P/E	25.19x
Industry P/E	28.16x
Lynch fair value	CNY 10.00
Lynch upside	-85.31%
P/B ratio	3.38x
P/E ratio	34.03x
P/OCF ratio	41.97x
P/S ratio	9.27x
Price / tangible book value	3.56x
Price/EBITDA ratio	32.02x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.44%
EBITDA margin	28.93%
Effective tax rate	7.61%
Gross margin	74.71%
Operating margin	21.44%
Pretax margin	29.27%
Profit margin	27.05%
Profit per employee	CNY 222,891
Profitable quarters	14
Profitable years	3
Revenue per employee	CNY 823,913
ROA	4.54%
ROA (5Y)	2.2%
ROCE	7.54%
ROE	10.17%
ROE (5Y)	5.97%
ROIC	11.03%
ROIC (5Y)	5.52%
Tax / revenue	2.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.08%
EPS growth (Q)	16.46%
EPS growth (QoQ)	-39.55%
EPS growth 3Y	67.86%
EPS growth 5Y	-4.84%
EPS growth quarters	1
EPS growth years	3
Gross profit growth	12.77%
Gross profit growth (Q)	18.32%
Gross profit growth 3Y	23.69%
Gross profit growth 5Y	-0.01%
Net income growth	27.83%
Net income growth (Q)	15.67%
Net income growth (QoQ)	-40.5%
Net income growth 3Y	70.02%
Net income growth 5Y	-3.53%
Net income growth quarters	1
Net income growth years	3
OCF growth	74.35%
OCF growth (Q)	-0.97%
OCF growth (QoQ)	-11.32%
OCF growth 5Y	-1.61%
Operating income growth	26.27%
Operating income growth (Q)	30.86%
Operating income growth 5Y	-8.67%
Revenue growth	13.69%
Revenue growth (Q)	16.91%
Revenue growth (QoQ)	-14.79%
Revenue growth 3Y	22.47%
Revenue growth 5Y	3.55%
Revenue growth quarters	1
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -1.3B
Depreciation and amortization	CNY 327.8M
EBIT	CNY 937.8M
EBITDA	CNY 1.3B
EPS	CNY 2.00
FCF per share	CNY -0.61
Financing cash flow	CNY 29.6M
Free cash flow	CNY -364.7M
Gross profit	CNY 3.3B
Income taxes	CNY 97.4M
Investing cash flow	CNY -1.2B
Net borrowing	CNY 226.4M
Net cash flow	CNY -208.8M
Net income	CNY 1.2B
Operating income	CNY 937.8M
Revenue	CNY 4.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CNY 20.26
Debt / EBITDA	0.18
Debt / equity	0.02
Interest coverage	8,633.68
Long-term assets	CNY 7B
Long-term liabilities	CNY 457.3M
Net cash (debt)	CNY 4B
Net cash / market cap	9.93%
Net cash growth	27.2%
Net debt / EBITDA	-3.18
Net debt / equity	-0.34
Piotroski F-Score	4
Property, plant and equipment	CNY 3.7B
Shareholders' equity	CNY 12B
Tangible book value	CNY 11.4B
Tangible book value per share	CNY 19.23
Total assets	CNY 13.7B
Total cash	CNY 4.3B
Total debt	CNY 235M
Total liabilities	CNY 1.7B
WACC	5.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.34
Current assets	CNY 6.7B
Current liabilities	CNY 1.2B
Current ratio	5.39
Inventory turnover	0.95
Net working capital	CNY 1.2B
Quick ratio	4.18
Working capital	CNY 5.5B
Working capital turnover	0.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.58%
Dividend growth	-33.33%
Dividend growth (3Y)	49.38%
Dividend growth (5Y)	2.13%
Dividend growth years	2
Dividend payment date	2026-05-29
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	CNY 1.00
Dividend yield	1.47%
Ex-dividend date	2026-05-29
Last dividend	CNY 1.00
Payout ratio	50.5%
Shareholder yield	0.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 64.29
1D price change	-0.37%
1M price change	-7.33%
1M total return	-7.33%
1W price change	-1.78%
1W total return	-1.78%
1Y price change	-4.84%
1Y return CAGR	-3.01%
1Y total return	-3.01%
20-day SMA	CNY 71.53
200-day SMA	CNY 65.03
3M price change	5.21%
3M total return	5.21%
3Y price change	48.15%
3Y return CAGR	15.96%
3Y total return	55.94%
50-day SMA	CNY 70.92
50-day SMA vs 200-day SMA	50over200
52-week high	CNY 79.99
52-week high date	2026-08-12
52-week low	CNY 51.51
52-week low date	2026-05-29
5Y price change	2.89%
5Y return CAGR	1.74%
5Y total return	9.01%
6M price change	13.49%
6M total return	15.67%
All-time high	CNY 204.41
All-time high date	2020-07-15
All-time low	CNY 30.53
All-time low date	2022-10-12
Average true range (ATR)	CNY 3.18
Average volume	9.3M
Beta (1Y)	0.53
Beta (2Y)	0.47
Beta (5Y)	0.26
Change from 52-week high	-14.91%
Change from 52-week low	32.13%
Change from all-time high	-66.7%
Change from all-time low	122.93%
Change from open	0.83%
Day's gap	-1.19%
Dollar volume	CNY 536.3M
High price	CNY 69.00
Low price	CNY 66.77
Monthly RSI	55.97
Open price	CNY 67.50
Position in 52-week range	57.85%
Previous close	CNY 68.31
Price vs 150-day SMA	5.86%
Price vs 20-day SMA	-4.86%
Price vs 200-day SMA	4.66%
Price vs 50-day SMA	-4.03%
Relative volume	0.86
RSI	44.68
Sharpe ratio	0.11
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	0.05
Sortino ratio	0.32
Sortino ratio (3Y)	1.1
Sortino ratio (5Y)	0.23
Volume	7.9M
Weekly RSI	51.71
YTD price change	-0.01%
YTD total return	1.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	339.3M
Shares change (QoQ)	-1.57%
Shares change (YoY)	0.58%
Shares held by insiders	35.16%
Shares held by institutions	9.49%
Shares outstanding	595.3M

Deeper analysis on SHA/603087

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/603087 report

Is a complete SHA/603087 research report available?

No complete published report is available for sha/603087 (SHA/603087) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/603087 (SHA/603087)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/603087

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/603087 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/603087

Frequently asked questions